JavaScript is required to use this site. Please enable JavaScript in your browser settings.

22. February 2022

Structural binding site comparisons reveal Crizotinib as a novel Lrrk2 Inhibitor.

Platzhalterbild
Previous Entry Back to Overview Next Entry
funded by:
Gefördert vom Bundesministerium für Bildung und Forschung.
Gefördert vom Freistaat Sachsen.